EQS-News
Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU)
- Evotec opens J.POD facility in Toulouse, France.
- New tech enables cost-effective biologics manufacturing.
- Facility enhances Europe's capacity for biotherapeutics.
EQS-News: Evotec SE / Key word(s): Miscellaneous
Hamburg, Germany, and Toulouse, France, 20 September 2024: During a ceremony on Campus Curie, Pierre-André Durand, Prefect of Haute-Garonne and Occitanie, Jean-Luc Moudenc, President of Toulouse Métropole and Mayor of Toulouse as well as Jalil Benabdillah, Vice-President, Economy, Employment, Innovation and Reindustrialisation of the Occitanie region, joined the Management of Evotec and Just – Evotec Biologics, to inaugurate the new facility. Dr Christian Wojczewski, Chief Executive Officer of Evotec, commented: “J.POD is a bioprocessing facility by Just – Evotec Biologics that uses advanced technology to fulfill its mission of making biotherapeutics more accessible worldwide. The opening of J.POD Toulouse, France (EU), our first J.POD on European ground, represents a proud moment and a significant milestone for our Company. We are very thankful for the support from the French government, the Occitanie Region, Bpifrance, the Haute-Garonne prefecture, and Toulouse Métropole for helping us achieve this milestone at our Campus Curie in Toulouse. We also want to give special credit to our dedicated team, whose hard work and commitment made this possible.” Diskutieren Sie über die enthaltenen Werte |